Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019

Deftereos, Spyridon; Γιαννόπουλος, Γεώργιος; A. Vrachatis, Dimitrios; Siasos, Gerasimos; G. Giotaki, Sotiria; Gargalianos, Panagiotis; Metallidis, Symeon; Sianos, George; Baltagiannis, S.; Panagopoulos, Periklis; Dolianitis, Konstantinos; Randou, Efthalia; Syrigos, Konstantinos; Kotanidou, Αnastasia; Koulouris, Νikolaos; Milionis, Haralampos; V. Sipsas, Nikolaos; Gogos, Charalampos; Tsoukalas, George; Olympios, Christoforos; P. Tsagalou, Eleftheria; Migdalis, Ilias; Gerakari, Styliani; Angelidis, Christos; Alexopoulos, Dimitrios; Davlouros, Periklis; Hahalis, George; Kanonidis, Ioannis; G. Katritsis, Demosthenes; M. Kolettis, Theofilos; S. Manolis, Antonis; K. Michalis, Lampros; Κ. Naka, Katerina; Pyrgakis, Vlasios; Tοutouzas, Konstantinos; Triposkiadis, Filippos; Tsioufis, Konstantinos; Vavouranakis, Emmanouil; Martínez‐Dolz, Luis; Reimers, Bernhard; Stefanini, Giulio; Cleman, Michael; Goudevenos, John; Tsiodras, Sotirios; Tousoulis, Dimitrios; K. Iliodromitis, Efstathios; Mehran, Roxana; Dangas, George; Stefanadis, Christodoulos; behalf of the GRECCO-19 investigators, on

doi:10.1001/jamanetworkopen.2020.13136

Public

Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019

Published in JAMA Network Open • Jun 24, 2020

Authors:

Spyridon Deftereos

Γεώργιος Γιαννόπουλος

Dimitrios A. Vrachatis

Abstract

Importance: Severe acute respiratory syndrome coronavirus 2 infection has evolved into a global pandemic. Low-dose colchicine combines anti-inflammatory action with a favorable safety profile. Objective: To evaluate the effect of treatment with colchicine on cardiac and inflammatory biomarkers and c...

Subject

Colchicine

Medicine

Coronavirus disease 2019 (COVID-19)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!